Effect of antipsychotic consumption during pregnancy on risk of gestational diabetes development
A systematic review and meta-analysis
Datos Bibliográficos
| ID | 15524933 |
|---|---|
| Autores | Jingna Liu (Red Cross Hospital, autor de correspondencia), Yanyan Zhao (0009-0005-8467-2801, Red Cross Hospital) |
| Año | 2026 |
| Volumen | 16 |
| Páginas | 1710101-1710101 |
| Fecha de publicación | 2026-02-10 |
| Peer Reviewed | Sí |
| Open Access | Sí |
| Tipo | ARTICLE |
| Revista | Frontiers in Psychiatry (JOURNAL) |
| Identificadores de la revista | ISSN: 1664-0640 • E-ISSN: 1664-0640 |
| Editorial | Frontiers Media (PUBLISHER • CH) |
| DOI | 10.3389/fpsyt.2025.1710101 |
| PMID | 41743828 |
| OpenAlex | W7128473228 |
| Idioma | EN |
| Referencias citadas | 27 |
The higher risk of GDM seen with antipsychotic use was mainly linked to SGAs, while FGAs did not show the same effect. These findings emphasize the need to tailor treatment plans, closely monitor blood sugar levels, and involve a team of healthcare professionals when caring for pregnant women who require psychotropic medications
Antipsychotic · Blood sugar · Consumption (sociology · Diabetes mellitus · Gestational diabetes · Health care · Pregnancy · Schizophrenia (object-oriented programming · Type 2 diabetes · Maternal Mental Health During Pregnancy and Postpartum · Pregnancy and Medication Impact · Schizophrenia research and treatment
| Velocidad de citación | historical |
|---|---|
| Altamente citado | No |